The current status of new platinum analogs.

Abstract

Nine platinum analogs are currently in clinical development, including three that contain the diaminocyclohexane substituent and five that contain the cyclobutanedicarboxylato leaving group. Many of them have shown activity in at least one cisplatin (CDDP)-resistant cell line, most commonly L1210 murine leukemia. In addition, most were less nephrotoxic than… (More)

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.